FLT3 and breast cancer: For anti-p-FLT3 Tyr842 or anti-p-cKIT Tyr719 detection, the MFI was also increased to a different degree upon BC treatment, although the overall intensity was very low, perhaps because the antibodies may not be suitable for a flow cytometry assay (Figure S1A–D).